Filing Details
- Accession Number:
- 0001209191-19-045636
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-12 19:23:10
- Reporting Period:
- 2019-08-12
- Accepted Time:
- 2019-08-12 19:23:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1029142 | Dynavax Technologies Corp | DVAX | Pharmaceutical Preparations (2834) | 330728374 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1573072 | F David Novack | C/O Dynavax Technologies 2100 Powell Street, Suite 900 Emeryville CA 94608 | Co-President And Senior Vp | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-08-12 | 16,667 | $3.00 | 118,484 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant (Right to Buy) | Acquisiton | 2019-08-12 | 4,167 | $0.00 | 4,167 | $4.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,167 | 2022-02-12 | No | 4 | P | Direct |
Footnotes
- Immediate